The dating platform for its third installment opens today vaccine and concerns according to the instructions of the National Vaccination Committee about 285,000 citizens.
As of yesterday, the citizens belonging to this category receive a reminder sms on their mobile phone to book appointments for the commemorative dose.
The third dose of vaccine will be mRNA vaccine (Pfizer or Moderna) for people who have received two doses of basic vaccine mRNA and one dose of mRNA vaccine for people who have received two doses of Astra Zeneca vaccine or one dose of Johnson vaccine. Johnson.
Who will do the third installment
The third dose will be given four weeks after the second dose to the following groups of high-risk patients:
– People with a transplant. Solid organ transplantation or hematopoietic cell transplantation.
– People on a waiting list for a transplant.
– People with renal insufficiency undergoing dialysis or peritoneal dialysis.
– Cancer under treatment.
Solid organ cancer in people undergoing treatment and treatment includes chemotherapy, radiation therapy, immunotherapy or other types of treatment.
– Hematological cancer during the last five years.
– Immunosuppressed people including patients with anti-inflammatory, autoimmune or other immunosuppressive diseases receiving specific immunomodulatory therapies, as well as people with primary immunodeficiency or people with HIV infection who have a CD4 count below 200.
The goal of the third installment
The booster dose is primarily aimed at “shielding” people who, due to illness or treatment, have not been able to have a satisfactory antibody response after basic vaccinations and remain vulnerable to infection.
Also, reactivation of the immune response, so as to create higher levels of antibodies and to make up for the reduction observed with antibody studies over time.
The National Vaccination Committee has concluded that the immunosuppressed will be followed for the third dose by the group of people living in Elderly Care Units on the one hand and the people over 60 years old.
At the same time, the data on the continuation of the classification of the population groups that will be vaccinated are evaluated, due to the risk of increased exposure or underlying problems, such as other chronic diseases.
READ ALSO